(20S) Ginsenoside Rh2 Inhibits STAT3/VEGF Signaling by Targeting Annexin A2

Overexpression of Annexin A2 promotes proliferation by forming a Glypican 1/c-Myc positive feedback loop: prognostic significance in human glioma

(2021) Xin Li et al.   Cell Death & Disease

Clinical significance of Annexin A2 expression in oral squamous cell carcinoma and its influence on cell proliferation, migration and invasion

(2021) Yingyi Ma et al.   Scientific Reports

YAP-dependent proliferation by a small molecule targeting annexin A2

(2021) Sophia Z. Shalhout et al.   Nature Chemical Biology

(20S)G-Rh2 Inhibits NF-κB Regulated Epithelial-Mesenchymal Transition by Targeting Annexin A2

(2020) Yu-Shi Wang et al.   Biomolecules

Prognostic features of Annexin A2 expression in prostate cancer

(2020) Shyh-Han Tan et al.   PATHOLOGY

STAT3 transcription factor as target for anti-cancer therapy

(2020) Aliaa M. Mohassab et al.   Pharmacological Reports

VEGF in Signaling and Disease: Beyond Discovery and Development

(2019) Rajendra S. Apte et al.   CELL

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

(2018) Daniel E. Johnson et al.   Nature Reviews Clinical Oncology

Annexin A2 (ANX A2): An Emerging Biomarker and Potential Therapeutic Target for Aggressive Cancers

(2018) Mahesh C. Sharma   INTERNATIONAL JOURNAL OF CANCER

Annexin A2 overexpression associates with colorectal cancer invasiveness and TGF-ß induced epithelial mesenchymal transition via Src/ANXA2/STAT3

(2018) Murilo R. Rocha et al.   Scientific Reports

The identification of molecular target of (20S) ginsenoside Rh2 for its anti-cancer activity

(2017) Yu-Shi Wang et al.   Scientific Reports

Ten years of anti-vascular endothelial growth factor therapy

(2016) Napoleone Ferrara et al.   NATURE REVIEWS DRUG DISCOVERY

Role of interleukin-6 in cancer progression and therapeutic resistance

(2016) Neeraj Kumari et al.   TUMOR BIOLOGY

S100 and annexin proteins identify cell membrane damage as the Achilles heel of metastatic cancer cells

(2015) Jyoti K Jaiswal et al.   CELL CYCLE

STAT3 the oncogene - still eluding therapy?

(2015) Matthew S. Wake et al.   FEBS Journal

Emerging strategies for cancer immunoprevention

(2015) J C Roeser et al.   ONCOGENE

Intracellular annexin A2 regulates NF-κB signaling by binding to the p50 subunit: implications for gemcitabine resistance in pancreatic cancer

(2015) H Jung et al.   Cell Death & Disease

Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells

(2015) Tong Wang et al.   Oncotarget

Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention

(2014) Ailian Xiong et al.   Cancers

Protein interactions between surface annexin A2 and S100A10 mediate adhesion of breast cancer cells to microvascular endothelial cells

(2013) Helene K. Myrvang et al.   FEBS LETTERS

Therapeutic modulators of STAT signalling for human diseases

(2013) Gabriella Miklossy et al.   NATURE REVIEWS DRUG DISCOVERY

Signal Transducer and Activator of Transcription 6 (STAT6) Is a Novel Interactor of Annexin A2 in Prostate Cancer Cells

(2010) Susobhan Das et al.   BIOCHEMISTRY

Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy

(2010) Napoleone Ferrara   NATURE MEDICINE